Catalyst Wire Dossier Catalyst Wire Dossier

ACDN-01

· Ascidian Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ACDN-01, covering 2025-12-02 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

See pricing